Please login to the form below

Not currently logged in
Email:
Password:

Boehringer names Ross Ullman as US consumer marketing director

His responsibilities will include developing the Zantac and Dulcolax brand visions

Ross Ullman has joined Boehringer Ingelheim's US operations as executive director, marketing for its consumer healthcare division.

He will be responsible for developing the Zantac and Dulcolax brand visions as part of a remit that includes annual planning, advertising and media development, brand innovation strategies and new product development.

“This is a position that is pivotal to Boehringer Ingelheim's continued success in the heartburn and constipation areas of our business, and we are proud to add Ross to our team,” said Marc Rovner, vice president and general manager, Consumer HealthCare Products.

“Through his vision and past successes, we are confident that Ross can help take Zantac and Dulcolax to the next level.”

Ullman joins the pharma company from Reckitt Benckiser, where he spent 14 years, most recently as marketing director for is $850m Lysol franchise.

During his time with the company he spearheaded Reckitt Benckiser's first ever social marketing brand platform, leveraging Facebook, bloggers and targeted community social sites to strengthen consumer engagement and sales.

“The players are different but the basics of marketing remain the same,” Ross said. “Now I'm getting a thorough education about the OTC universe and what motivates consumers in this industry. These are strong brands with great growth potential. My job now is simply to help deliver that growth.”

29th May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics